EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer

Ren Nanamiya(Tohoku University), Hironobu Sasano(Tohoku University)
International Journal of Molecular Sciences
August 7, 2021
Cited by 14


Related Papers